pentoxifylline has been researched along with Irritable Bowel Syndrome in 1 studies
Irritable Bowel Syndrome: A disorder with chronic or recurrent colonic symptoms without a clearcut etiology. This condition is characterized by chronic or recurrent ABDOMINAL PAIN, bloating, MUCUS in FECES, and an erratic disturbance of DEFECATION.
| Excerpt | Relevance | Reference |
|---|---|---|
| " The aim of this study was to examine whether pentoxifylline, a competitive nonselective phosphodiesterase inhibitor, is useful in alleviating abdominal pain in IBS patients treated with mebeverine." | 9.51 | Pentoxifylline, a nonselective phosphodiesterase inhibitor, in adjunctive therapy in patients with irritable bowel syndrome treated with mebeverine. ( Abd-Elsalam, SM; Bahaa, MM; El-Haggar, SM; Hegazy, SK, 2022) |
| " The aim of this study was to examine whether pentoxifylline, a competitive nonselective phosphodiesterase inhibitor, is useful in alleviating abdominal pain in IBS patients treated with mebeverine." | 5.51 | Pentoxifylline, a nonselective phosphodiesterase inhibitor, in adjunctive therapy in patients with irritable bowel syndrome treated with mebeverine. ( Abd-Elsalam, SM; Bahaa, MM; El-Haggar, SM; Hegazy, SK, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| El-Haggar, SM | 1 |
| Hegazy, SK | 1 |
| Abd-Elsalam, SM | 1 |
| Bahaa, MM | 1 |
1 trial available for pentoxifylline and Irritable Bowel Syndrome
| Article | Year |
|---|---|
Pentoxifylline, a nonselective phosphodiesterase inhibitor, in adjunctive therapy in patients with irritable bowel syndrome treated with mebeverine.
Topics: Abdominal Pain; Adult; Anti-Inflammatory Agents; Drug Therapy, Combination; Female; Humans; Irritabl | 2022 |